Patient Controlled Injectors Market Size And Share

  • Report Code : TIPRE00015234
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Patient Controlled Injectors Market Share, Trends, and Analysis by 2031

Buy Now

Patient Controlled Injectors Market Report Patient Controlled Injectors Market Scope and Analysis Patient Controlled Injectors Market Size and Share

Patient Controlled Injectors Market: Strategic Insights

Patient Controlled Injectors Market

  • CAGR (2023 - 2031)
    12.9%
  • Market Size 2021
    US$ 3.71 Billion
  • Market Size 2031
    US$ 12.33 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising Prevalence of Chronic Diseases
  • Rising Patient Compliance
FUTURE TRENDS
  • Technology Advancements in Wearable Injector
OPPORTUNITIES
  • Adoption of Self-Administered Medication

Key Players

  • Gerresheimer AG
  • Johnson and Johnson Services Inc
  • Ypsomed AG
  • Westbourne Medical Limited
  • Enable Injections
  • scPharmaceuticals Inc
  • United Therapeutics Corporation
  • BD
  • West Pharmaceutical Services Inc
  • Owen Mumford Pharmaceutical Services

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Electronic Wearable Injectors
  • Mechanical Wearable Injectors
  • Infusion Pumps
Application
  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies